| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Center for Research on Occupational and Environmental Toxicology (C.N., M.I., H.G., M.R., N.F., C.A.), Departments of Physiology and Pharmacology and Behavioral Neuroscience (K.N.), Oregon Health Sciences University, Portland, Oregon 97201; Medical Research Service (K.N.), Veterans Affairs Medical Center, Portland, Oregon 97201; Advanced Research Institute for Science and Engineering (M.I.), Waseda University, Tokyo 169, Japan; and Department of Molecular Neurobiology (T.Y.), School of Human Sciences, Waseda University, Tokorozawa 359, Japan
Address all correspondence and requests for reprints to: Charles N. Allen, CROET L606, Oregon Health Sciences University, 3181 S.W. Sam Jackson Park Road, Portland, Oregon 97201. E-mail: allenc{at}ohsu.edu
Melatonin is a pineal hormone that regulates seasonal reproduction and has been used to treat circadian rhythm disorders. The melatonin 1a receptor is a seven- transmembrane domain receptor that signals predominately via pertussis toxin-sensitive G-proteins. Point mutations were created at residue N124 in cytoplasmic domain II of the receptor and the mutant receptors were expressed in a neurohormonal cell line. The acidic N124D- and E-substituted receptors had high-affinity 125I-melatonin binding and a subcellular localization similar to the neutral N124N wild-type receptor. Melatonin efficacy for the inhibition of cAMP by N124D and E mutations was significantly decreased. N124D and E mutations strongly compromised melatonin efficacy and potency for inhibition of K+-induced intracellular Ca++ fluxes and eliminated control of spontaneous calcium fluxes. However, these substitutions did not appear to affect activation of Kir3 potassium channels. The hydrophobic N124L and N124A or basic N124K mutations failed to bind 125I-melatonin and appeared to aggregate or traffic improperly. N124A and N124K receptors were retained in the Golgi. Therefore, mutants at N124 separated into two sets: the first bound 125I-melatonin with high affinity and trafficked normally, but with reduced inhibitory coupling to adenylyl cyclase and Ca++ channels. The second set lacked melatonin binding and exhibited severe trafficking defects. In summary, asparagine-124 controls melatonin receptor function as evidenced by changes in melatonin binding, control of cAMP levels, and regulation of ion channel activity. Asparagine-124 also has a unique structural effect controlling receptor distribution within the cell.
This article has been cited by other articles:
 |
|
 |
|
  A. Slominski, J. Wortsman, and D. J. Tobin The cutaneous serotoninergic/melatoninergic system: securing a place under the sun FASEB J, February 1, 2005; 19(2): 176 - 194. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Ikeda, S. Suzuki, M. Kishio, M. Hirono, T. Sugiyama, J. Matsuura, T. Suzuki, T. Sota, C. N. Allen, S. Konishi, et al. Hydrogen-Deuterium Exchange Effects on {beta}-Endorphin Release from AtT20 Murine Pituitary Tumor Cells Biophys. J., January 1, 2004; 86(1): 565 - 575. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. Steffens, X.-B. Zhou, U. Sausbier, C. Sailer, K. Motejlek, P. Ruth, J. Olcese, M. Korth, and T. Wieland Melatonin Receptor Signaling in Pregnant and Nonpregnant Rat Uterine Myocytes as Probed by Large Conductance Ca2+-Activated K+ Channel Activity Mol. Endocrinol., October 1, 2003; 17(10): 2103 - 2115. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. I. Masana and M. L. Dubocovich Melatonin Receptor Signaling: Finding the Path Through the Dark Sci. Signal., November 6, 2001; 2001(107): pe39 - pe39. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |
